U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
173041173041The Effect of FES on Children With Spinal Cord InjuryCompletedHas ResultsSpinal Cord InjuryDevice: RT 300-P FES Cyclehttps://ClinicalTrials.gov/show/NCT00291317
173042173042Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast CarcinomaTerminatedNo Results Available#NAME?Procedure: MRIhttps://ClinicalTrials.gov/show/NCT00291304
173043173043Effects of Endometriosis on Bone Mineral DensityCompletedNo Results AvailableEndometriosishttps://ClinicalTrials.gov/show/NCT00291278
173044173044Measures of Motor Impairment in Early Parkinson's DiseaseCompletedNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00291265
173045173045Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major DepressionActive, not recruitingNo Results AvailableMajor DepressionBehavioral: partial sleep deprivationhttps://ClinicalTrials.gov/show/NCT00291239
173046173046Glycine vs Placebo for the Schizophrenia ProdromeCompletedNo Results AvailableSchizophrenia ProdromeDrug: Glycine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00291226
173047173047Levetiracetam Treatment of Tardive DyskinesiaCompletedNo Results AvailableTardive DyskinesiaDrug: levetiracetam|Drug: placebohttps://ClinicalTrials.gov/show/NCT00291213
173048173048Enhancing the Prospective Prediction of PsychosisCompletedNo Results AvailableSchizophrenia|Psychotic Disordershttps://ClinicalTrials.gov/show/NCT00291200
173049173049VEC-162 Study in Healthy Adult Volunteers in a Model of InsomniaCompletedHas ResultsInsomniaDrug: 20 mg VEC-162|Drug: 50 mg VEC-162|Drug: 100 mg VEC-162|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00291187
173050173050Measuring Electrical Resistance of Different Tissues on the Outer Surface of the HeartTerminatedNo Results AvailableCardiomyopathies|Ventricular Dysfunction|Myocardial Infarction|Arrhythmiahttps://ClinicalTrials.gov/show/NCT00291174
173051173051Partners in Dementia CareCompletedNo Results AvailableDementia|Alzheimer DiseaseBehavioral: Care Coordination in Primary Care|Behavioral: Care Coordination in Alz. Associationhttps://ClinicalTrials.gov/show/NCT00291161
173052173052Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic PainCompletedNo Results AvailableNeuropathic Pain|Multiple SclerosisDrug: paroxetine|Drug: pregabalin|Drug: Paroxetinehttps://ClinicalTrials.gov/show/NCT00291148
173053173053Protocol for Women at Increased Risk of Developing Breast CancerCompletedHas ResultsBreast CancerDrug: letrozolehttps://ClinicalTrials.gov/show/NCT00291135
173054173054An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast CancerCompletedNo Results AvailableBreast CancerDrug: celecoxib 400 mg BIDhttps://ClinicalTrials.gov/show/NCT00291122
173055173055An Examination of Predictors of Indicators of Response to Letrozole 2.5 mgCompletedNo Results AvailableBreast CancerDrug: letrozole 2.5 mghttps://ClinicalTrials.gov/show/NCT00291109
173056173056Protocol for Women at Increased Risk of Developing Breast CancerRecruitingNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00291096
173057173057Protocol for Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00291083
173058173058Effects of L-Theanine in Boys With ADHDCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: L-theaninehttps://ClinicalTrials.gov/show/NCT00291070
173059173059Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head LiceTerminatedNo Results AvailableLice InfestationsDrug: MALGhttps://ClinicalTrials.gov/show/NCT00291057
173060173060HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant WomenCompletedNo Results AvailablePregnancyOther: testing for HSV 1 and 2 IgG type specific antibosyhttps://ClinicalTrials.gov/show/NCT00291044
173061173061Study of the Effect of Imagery Rehearsal Therapy (IRT) of NightmaresCompletedNo Results AvailableNightmares|Anxiety Disorders|Mood Disorders|Personality DisordersBehavioral: Imagery Rehearsal Therapy (IRT)https://ClinicalTrials.gov/show/NCT00291031
173062173062Safety and Efficacy Study Comparing ProDisc-C to ACDF Surgery to Treat SCDDCompletedNo Results AvailableSymptomatic Cervical Disc DiseaseDevice: Total Disc Replacement|Device: ACDFhttps://ClinicalTrials.gov/show/NCT00291018
173063173063PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With PrednisoloneCompletedNo Results AvailableProstatic NeoplasmsDrug: ARD6562, Docetaxelhttps://ClinicalTrials.gov/show/NCT00291005
173064173064Rasburicase for HyperuricemiaCompletedNo Results AvailableNutritional and Metabolic DiseasesDrug: rasburicase (SR29142)https://ClinicalTrials.gov/show/NCT00290992
173065173065Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: insulin glulisinehttps://ClinicalTrials.gov/show/NCT00290979
173066173066Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCompletedNo Results AvailableStomach NeoplasmDrug: XRP6976https://ClinicalTrials.gov/show/NCT00290966
173067173067Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + EtoposideCompletedNo Results AvailableLung Cancer|Pulmonary Neoplasms|Small Cell Lung CancerDrug: SR48692https://ClinicalTrials.gov/show/NCT00290953
173068173068Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: CS-917|Drug: metformin hydrochloride|Drug: pioglitazonehttps://ClinicalTrials.gov/show/NCT00290940
173069173069Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: insulin glulisinehttps://ClinicalTrials.gov/show/NCT00290927
173070173070Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: Vilazodonehttps://ClinicalTrials.gov/show/NCT00290914

* Görseller ve İçerik tekif hakkına sahip olabilir